Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it has closed its previously announced registered direct offering of…

Read MoreMyomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Global Automated Blood Tube Labelers and Specimen Transport Boxes Strategic Research Report 2024 – ResearchAndMarkets.com

-The “Automated Blood Tube Labelers and Specimen Transport Boxes – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. Global Automated Blood Tube Labelers and Specimen Transport Boxes Market to Reach $518.8 Million by 2030 The global market for Automated Blood Tube Labelers…

Read MoreGlobal Automated Blood Tube Labelers and Specimen Transport Boxes Strategic Research Report 2024 – ResearchAndMarkets.com

Dexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland

(Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, has officially broken ground on its new state-of-the-art manufacturing facility, located in Athenry, Co. Galway. This marks the first step in the realisation of this…

Read MoreDexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland

Kindeva Drug Delivery acquires Summit Biosciences, a company specializing in the development and manufacturing of nasally administered drugs

 Kindeva Drug Delivery (“Kindeva”), a global leader in drug and device combination products, today announced the acquisition of Summit Biosciences Inc. ( “Summit”), an intranasal drug development and manufacturing organization (CDMO), with its founding family shareholders. Established in 2009, Summit has a long history…

Read MoreKindeva Drug Delivery acquires Summit Biosciences, a company specializing in the development and manufacturing of nasally administered drugs

Hologram Sciences at the World Economic Forum, or AI serving global health through precision nutrition

By Taking an AI-Powered Approach to Combat Malnutrition, Hologram Sciences Strengthens Precision Nutrition Platform At the 54th World Economic Forum, Hologram Sciences , an AI-driven health technology company, outlines its commitment to addressing historic healthcare challenges, particularly the malnutrition of patients. The company’s…

Read MoreHologram Sciences at the World Economic Forum, or AI serving global health through precision nutrition

Sensorion Receives Authorization to Initiate a Phase 1/2 Clinical Trial for SENS-501 (OTOF-GT), its Most Advanced Gene Therapy Candidate, in Select European Countries

a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announces that it has received approval of its application to initiate a Phase 1/2 clinical trial (CTA) with SENS-501…

Read MoreSensorion Receives Authorization to Initiate a Phase 1/2 Clinical Trial for SENS-501 (OTOF-GT), its Most Advanced Gene Therapy Candidate, in Select European Countries

Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved

Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Hackensack Meridian Health (“HMH”), a leading not-for-profit health care organization and the largest, most comprehensive and truly integrated network in New…

Read MoreCompass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved

New OmniSYS XiFin Pharmacy Solutions CareALERTS™ Data Demonstrate Critical Role Pharmacists Play as Healthcare Providers

CareALERTS closes healthcare gaps including raising immunizations rates among seniors and adults On National Pharmacist Day, XiFin celebrates pharmacists and urges all U.S. states to recognize pharmacists as providers OmniSYS, the pharmacy division of XiFin, Inc., announced its 2023 end-of-year…

Read MoreNew OmniSYS XiFin Pharmacy Solutions CareALERTS™ Data Demonstrate Critical Role Pharmacists Play as Healthcare Providers